Ade Adamson, MD MPP (@adeadamson) 's Twitter Profile
Ade Adamson, MD MPP

@adeadamson

Dermatologist | Health Services Researcher | Alum: @Morehouse @HarvardMed @MIT_HST @Kennedy_School | A naive EBM aficionado| Cancer researcher | Melanoma expert

ID: 3067167046

linkhttp://www.adeadamson.com/ calendar_today03-03-2015 04:26:18

17,17K Tweet

8,8K Followers

953 Following

Adam Cifu (@adamcifu) 's Twitter Profile Photo

This is so powerful. We need to do things to reduce disparities that actually reduce disparities. Great work Ade Adamson, MD MPP Doing more cancer screening won’t reduce Black-white health disparities statnews.com/2024/08/21/can… via STAT

Seth M Hardy, MD MBA (@sethmhardy) 's Twitter Profile Photo

Adam Cifu Ade Adamson, MD MPP STAT So glad to see others making this point. A low SES single mother ain’t got no time for false positive results. However if you have a nice blue cross card in your pocket book, it’s no sweat.

<a href="/adamcifu/">Adam Cifu</a> <a href="/AdeAdamson/">Ade Adamson, MD MPP</a> <a href="/statnews/">STAT</a> So glad to see others making this point. 

A low SES single mother ain’t got no time for false positive results. 

However if you have a nice blue cross card in your pocket book, it’s no sweat.
david ropeik (@dropeik) 's Twitter Profile Photo

A vital, eloquent, throughly researched message. Our blind faith in cancer screening is being tapped to solve a problem it can't solve. Please read and share this piece Doing more cancer screening won’t reduce Black-white health disparities statnews.com/2024/08/21/can… via STAT

Anil Makam (@anilmakam) 's Twitter Profile Photo

"However well-intentioned, screening is a symbolic health equity solution that serves more the interests of those with advanced degrees, than those with high school educations." 🔥 piece from Ade Adamson, MD MPP & co statnews.com/2024/08/21/can…

NICE (@nicecomms) 's Twitter Profile Photo

Our committee is unable to recommend lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease. Benefits of slowing disease progression, by 4-6 months on average, can not justify the high cost to the NHS. Learn more: nice.org.uk/news/articles/…

Our committee is unable to recommend lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease.

Benefits of slowing disease progression, by 4-6 months on average, can not justify the high cost to the NHS.

Learn more: nice.org.uk/news/articles/…
CSPH (@csph_bwh) 's Twitter Profile Photo

Does more cancer screening reduce Black-white health disparities? Ade Adamson, MD MPP, Vishal Patel, and Dr. Gil Welch argue that increasing cancer screening primarily serves the interests of the health care system rather than the needs of our communities. statnews.com/2024/08/21/can…

HealthBegins (@healthbegins) 's Twitter Profile Photo

"To move toward true #healthequity, interventions must prioritize community needs over system needs." #SDOH Doing more cancer screening won’t reduce Black-white health disparities buff.ly/4dwtkb7 by Ade Adamson, MD MPP Vishal Patel via STAT CC: Brigham and Women’s Department of Surgery Brigham and Women's Hospital

"To move toward true #healthequity, interventions must prioritize community needs over system needs." #SDOH

Doing more cancer screening won’t reduce Black-white health disparities buff.ly/4dwtkb7 by <a href="/AdeAdamson/">Ade Adamson, MD MPP</a> <a href="/vrpatel97/">Vishal Patel</a> via <a href="/statnews/">STAT</a> CC: <a href="/BrighamSurgery/">Brigham and Women’s Department of Surgery</a> <a href="/BrighamWomens/">Brigham and Women's Hospital</a>